Guido Kroemer, Ph.D., is best known for the discovery that the permeabilization of mitochondrial membranes constitutes a decisive step in programmed cell death. He has explored the fine mechanisms of mitochondrial cell death control, the molecular pathways that explain the inhibition of cell death in cancer cells, upstream of or at the level of mitochondria, and the mechanisms that make cancer cell death immunogenic. His work has had far reaching implications for the comprehension, detection and therapeutic manipulation of cellular demise. His contributions have been recognized with numerous awards, including the Descartes Prize of the European Union, the Carus Medal of the German Academy of Sciences, the Grand Prix Mergier-Bourdeix of the French Academy of Sciences, the Dautrebande Prize of the Belgian Royal Academy of Medicine, the Gallet and Breton Prize of the French Academy of Medicine and others. He currently serves on more than 40 Editorial Boards. These include EMBO Journal, EMBO Reports, Cancer Research, Oncogene and Cell Death and Differentiation. he serves as the Editor-in-Chief of Cell Death and Disease. A prolific scholar, he has more than 600 scientific publications with about 52,000 citations. He is currently the most cited scientist worldwide in the field of cell death as well as in the area of mitochondrial research. He has delivered numerous keynote addresses at symposia internationally. He is a Member of EMBO, German Academy of Sciences (Leopoldina), Academia Europaea, European Academy of Sciences (EAS), and European Academy of Sciences and Arts (EASA). He serves as the President Elect of the European Cell Death Organization (ECDO) and as the Founding Director of the European Research Institute for Integrated Cellular Pathology (ERI-ICP).
Biography Updated on 28 August 2011